Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
61
datasets available to search
ShareScore release 0.9.0
Dataset results
61 results for “RAS mutant”
Supplement for "Up-regulated transcriptional regulators in mutant RAS gene signatures – a time-resolved multi-omics study in generic epithelial cell models"
<p>This is the supplementary material for the biorxiv submission with the title "Identification of up-regulated transcriptional regulators in mutant RAS gene signatures – a time-resolved multi-omics study in a generic epithelial cell model".</p>
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
ClinicalTrials.gov study NCT07198321. IPD Sharing: NO. Countries: 1. Publications: 0.
Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01915602. IPD Sharing: Not stated. Countries: 21. Publications: 0.
Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloprolif
ClinicalTrials.gov study NCT06284460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
ClinicalTrials.gov study NCT07318324. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
ClinicalTrials.gov study NCT06194877. IPD Sharing: YES. Countries: 2. Publications: 0.
mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases
ClinicalTrials.gov study NCT04781270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01915589. IPD Sharing: Not stated. Countries: 17. Publications: 0.
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
ClinicalTrials.gov study NCT03597581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05634590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
ClinicalTrials.gov study NCT05554367. IPD Sharing: YES. Countries: 2. Publications: 0.
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
ClinicalTrials.gov study NCT07213570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
ClinicalTrials.gov study NCT02619435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)
ClinicalTrials.gov study NCT01281761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for St
ClinicalTrials.gov study NCT00655161. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing) of WT and RAS mutant specimens from acute myeloid leukemia (AML) patients.
GEO Series GSE156041. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
MEK inhibition profoundly reprograms myogenic super enhancers in mutant-RAS driven Rhabdomyosarcoma
GEO Series GSE85169. Homo sapiens. 38 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Mechanisms of response and tolerance to active RAS inhibition in KRAS-mutant NSCLC
GEO Series GSE270541. Mus musculus. 35 samples. Type: Expression profiling by high throughput sequencing.
Gene expression profiles of Ras mutants.
GEO Series GSE14934. Homo sapiens. 25 samples. Type: Expression profiling by array.
NSCLC metastasis: K-ras/p53 mutant and syngeneic mouse models
GEO Series GSE14459. Mus musculus. 28 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.